Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends

NCT07341464 — Not applicable, Recruiting, 50 participants, Société des Produits Nestlé (SPN)

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Acceptability (Including Gastrointestinal Tolerance and Compliance) of a Paediatric and Adult Bolus Tube Feed With Food Blends

RegistryNCT07341464, acronym Blends
StatusRecruiting
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, health services research
Enrollment50 (Estimated)
SponsorSociété des Produits Nestlé (SPN) (Industry)
ConditionsCerebral Palsy (CP), Oncology
InterventionsTube feed (Dietary supplement)
Datesstart 2025-12-10, primary completion 2026-11-10 (estimated), completion 2026-11-11 (estimated), first posted 2026-01-14, last updated 2026-01-14
Locations2 sites in United Kingdom

Related Papers Related Patents Related Grants Related Experts
All trials for Cerebral Palsy (CP) All trials for Oncology All trials of Tube feed

-Summary

This is a prospective acceptability study to evaluate the gastrointestinal tolerance and compliance of a bolus tube feed over a 28 -day period for up to 50 participants.

The enteral bolus formula is for the dietary management of patients with short bowel syndrome; intractable malabsorption; preoperative preparation of undernourished patients; inflammatory bowel disease; total gastrectomy; dysphagia; bowel fistulae; feeding intolerances, developmental disabilities, and disease related malnutrition.

Expand all sections  ·  Collapse all

+Detailed description

The study will collect data in 50 children and adults over a period of 28 days. Gastrointestinal tolerance will be collected over 7 days and formula intake will be over 28 days. A patient satisfaction questionnaire will be completed at the end of the study.

+Arms and interventions

ArmTypeInterventionsDescription
Acceptability and Tolerance Study of bolus tube feed with food blendsOtherDietary Supplement: Tube feedArm one will act as their own controls
  • Tube feed (Dietary supplement): Dose intake and duration.

+Outcome measures

Primary outcomes

  • Measure of Gastrointestinal tolerance [7 days]: Severity of symptoms such as reflux, vomiting, constipation, diarrhoea as a four-point likert scale (none, mild, moderate, severe).
  • Daily record of formula intake. [28 days]: Measure of formula intake in mL.

+Eligibility

Sex: All, ages: 1 Year to any

Inclusion Criteria:

* Patients from 1 -15 years for children and 15 years and above for adults of requiring 1 or more bolus tube feed alongside their usual tube feed or home-made blended diet as part of their dietary management for disease related malnutrition.
* Patients well-established and stable on current enteral tube feed or home-made blended diet.
* Gastrostomy fed only.
* Willingly given, written, informed consent from patient/caregiver

Exclusion Criteria:

* Inability to comply with the study protocol, in the opinion of the investigator.
* Under 1 years of age
* Patients who have a nasogastric and jejunal feeding tubes
* Patients on total parenteral nutrition
* Known food allergies to any ingredients listed in appendix 1.
* Patients with significant renal or hepatic impairment
* Participation in another interventional study within 2 weeks of this study.
* Patients with known or suspected ileus or mechanical bowel obstruction

+Locations (2)

FacilityCityCountryStatus
Queen Medical Hospital Nutrition and DieteticsNottinghamUnited KingdomNot yet recruiting
Dietetic Team 1st floor Kings Court 1, Charles Hastings Way,WorcesterUnited KingdomRecruiting